CF
COCH icon

Cantor Fitzgerald’s Envoy Medical COCH Stock Holding History

Cantor Fitzgerald’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-292,812
Closed -$2.88M – 725
2022
Q3 		$2.88M Hold
292,812
– – 0.06% 298
2022
Q2 		$2.87M Hold
292,812
– – 0.06% 320
2022
Q1 		$2.86M Buy
+292,812
New +$2.85M 0.22% 116

Other funds holding COCH

AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return

Cantor Fitzgerald's COCH Position: Q4 2022 in Review

Cantor Fitzgerald sold out of Envoy Medical (COCH) in Q4 2022, closing a stake of 292,812 shares — an estimated $2.88M sold.

Cantor Fitzgerald first reported a position in COCH in Q1 2022 and held it in 3 quarters. The position peaked at $2.88M in Q3 2022. 93 funds tracked by Wall St. Rank hold COCH as of Q4 2022.

  • Cantor Fitzgerald reported no remaining Envoy Medical position as of Q4 2022 after selling out during the quarter.
  • Cantor Fitzgerald sold 292,812 Envoy Medical shares in Q4 2022, an estimated $2.88M.
  • Cantor Fitzgerald first reported a position in Envoy Medical in Q1 2022 and held it in 3 quarters.
  • Cantor Fitzgerald's Envoy Medical position peaked at $2.88M in Q3 2022.
  • 93 funds tracked by Wall St. Rank held Envoy Medical as of Q4 2022.

Based on Cantor Fitzgerald's 13F filing for Q4 2022, filed 14 Feb 2023.